NYBC Ventures
Venture Capital
Early-stage life sciences VC fund accelerating breakthroughs in blood, cellular therapies, hematology, transfusion medicine, and infectious disease.
Early Stage
Cell Therapy
Hematology
Infectious Disease
Transfusion Medicine
- Headquarters
- Boston, United States
- Founded
- 2021
- Website
- nybcventures.com
- AUM
- $50.0M
- Last Investment
- Oct 2024
- Geographic Focus
- United States
Investment Thesis
Elevates investment performance leveraging New York Blood Center’s expertise in blood and cellular therapies to support visionary founders.
Investment History
Sign up to view investment history
Create a free account to see deal history, investment amounts, and round details.
Create Free Account